Information  X 
Enter a valid email address

Celtic PLC (CCP)

  Print          Annual reports

Tuesday 25 September, 2018

Celtic PLC

Issue of Equity

RNS Number : 9223B
Celtic PLC
25 September 2018


Issued share capital


As a result of the conversion of 19,200 Convertible Cumulative Preference Shares of 60p each and 4,000 Convertible Preferred Ordinary Shares of 100p each, Celtic PLC's issued share capital as at 25 September 2018 was as follows:


93,878,190           Ordinary Shares of 1p each ("Ordinary Shares")                        

12,903,679           Convertible Preferred Ordinary Shares of 100p each ("CPO Shares")

15,893,745           Convertible Cumulative Preference Shares of 60p each ("CCP Shares")

654,019,716         Deferred Shares of 1p each ("Deferred Shares")


CCP Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights. 


The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure Guidance and Transparency Rules.


Application has been made for the admission of 27,520 new Ordinary Shares of 1p each arising from these conversions ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, will commence on 2 October 2018.






Michael Nicholson, Company Secretary 

0141 551 4298

Canaccord Genuity Limited


Simon Bridges, Nominated Adviser     

020 7523 8350



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t